The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure

American Heart Journal

Volumn 154, Issue 1, 2007, Pages 123-129

  Schou, Morten ^a   Gustafsson, Finn ^b   Corell, Pernille ^a   Kistorp, Caroline N ^a   Kjaer, Andreas ^b,c   Hildebrandt, Per R ^d  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ALGORITHM; ARTICLE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 34250341747     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.002     Document Type: Article

References (25)

1. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
2. Doust J.A., Pietrzak E., Dobson A., et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
3. Masson S., Latini R., Anand I.S., et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure(Val-HeFT) data. Clin Chem 52 (2006) 1528-1538
4. Richards A.M., Doughty R., Nicholls M.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 37 (2001) 1781-1787
5. Gardner R.S., Ozalp F., Murday R.J., et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
6. Hartmann F., Packer M., Coats A.J., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786
7. Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
8. Gustafsson F., Ulriksen H., Villadsen H., et al. Prevalence and characteristics of heart failure clinics in Denmark-design of the Danish heart failure clinics network. Eur J Heart Fail 7 (2005) 283-284
9. Stromberg A., Martensson J., Fridlund B., et al. Nurse-led heart failure clinics in Sweden. Eur J Heart Fail 3 (2001) 139-144
10. Jaarsma T., Tan B., Bos R.J., et al. Heart failure clinics in the Netherlands in 2003. Eur J Cardiovasc Nurs 3 (2004) 271-274
11. Galatius S., Gustafsson F., Nielsen P.H., et al. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 144 (2002) E2
12. Junge W., Wilke B., Halabi A., et al. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffe method. Clin Chim Acta 344 (2004) 137-148
13. Sokoll L.J., Baum H., Collinson P.O., et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 42 (2004) 965-972
14. Olsen M.H., Hansen T.W., Christensen M.K., et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46 (2005) 660-666
15. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
16. Gustafsson F., Steensgaard-Hansen F., Badskjaer J., et al. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J Card Fail 11 (2005) S15-S20
17. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
18. McKie P.M., Rodeheffer R.J., Cataliotti A., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 47 (2006) 874-880
19. Corell P., Gustafsson F., Markenvard J., et al. Prevalence and prognostic significance of atrial fibrillation in outpatients with systolic heart failure. Eur J Heart Fail 9 (2007) 258-265
20. Felker G.M., Shaw L.K., and O'Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39 (2002) 210-218
21. Gustafsson F., Torp-Pedersen C., Seibaek M., et al. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J 25 (2004) 1711-1717
22. Gustafsson F., Torp-Pedersen C., Brendorp B., et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24 (2003) 863-870
23. Gustafsson F., Kragelund C.B., Torp-Pedersen C., et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J 26 (2005) 58-64
24. Gustafsson I., Brendorp B., Seibaek M., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43 (2004) 771-777
25. Jaarsma T., Van Der Wal M.H., Hogenhuis J., et al. Design and methodology of the COACH study: a multicenter randomised coordinating study evaluating outcomes of advising and counselling in heart failure. Eur J Heart Fail 6 (2004) 227-233